Manufacturing and Production

Showing 15 posts of 5857 posts found.

90ten_team_photo

Envision Pharma Group acquires healthcare comms consultancy 90TEN

April 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90TEN, Envision Pharma Group, pharma

Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, it has been revealed. 90TEN said that it …
mcintyre-headshot

Dr Maritza McIntyre appointed Chief Development Officer at StrideBio

April 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

StrideBio have announced the appointment of Maritza McIntyre Ph.D., as its first Chief Development Officer. The newly created role will …

Inovio’s coronavirus vaccine, funded by Bill Gates, begins human trials

April 7, 2020 Manufacturing and Production COVID-19, coronavirus, coronavirus vaccine

Inovio’s coronavirus vaccine has entered human trials after the FDA approved its application to begin them under the Investigational New …

Martin Shkreli asks to be furloughed from prison to work on COVID-19 treatments

April 7, 2020 Manufacturing and Production COVID-19, Pharma Bro, coronavirus

Disgraced biotech entrepreneur Martin Shkreli, also known as the ‘Pharma Bro’, is asking for a brief furlough from prison to …
stock-incyte-01-shutter

Incyte’s ruxolitinib cream formulations look strong in Phase 3 atopic dermatitis

April 7, 2020 Manufacturing and Production, Research and Development Incyte, atopic dermatitis, ruxolitinib

Incyte has lifted the curtain on promising new Phase 3 data for its 0.75% and 1.5% twice daily cream formulations …
modi

Donald Trump talks of “retaliation” if India does not export hydroxychloroquine to the US

April 7, 2020 Manufacturing and Production American coronavirus, COVID-19, Donald Trump, coronavirus

United States President Donald Trump has suggested that the US may retaliate if India did not export the anti-malaria drug …
takeda_usa_pharmaceuticals_u

Takeda’s Alunbrig outclasses Xalkori to secure EU approval in ALK+ advanced non-small cell lung cancer

April 7, 2020 Manufacturing and Production, Sales and Marketing Alunbrig, Europe, Takeda, pharma

The European Commission has ruled to expand the current approved indication of Takeda’s Alunbrig (brigatinib), authorising the drug as a …
fda2outsideweb

FDA approval for BMS and Acceleron’s Reblozyl to reduce red blood cell transfusion dependence

April 6, 2020 Manufacturing and Production, Sales and Marketing BMS, FDA, Reblozyl, pharma

The FDA has given the regulatory thumbs-up in the US of Reblozyl (luspatercept-aamt), the “first and only erythroid maturation agent” …
david_setboun

Industry veteran Dr David Setboun joins BrainStorm as Executive VP and COO

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BrainStorm Therapeutics, appointments, pharma

BrainStorm Cell Therapeutics, a firm developing cellular therapies to tackle neurodegenerative diseases, has named industry Big Pharma veteran Dr David …
john-mckew-big

Dr John C. McKew promoted to Chief Operating Officer at Lumos Pharma

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lumos Pharma, Inc. has promoted Dr John McKew to the position of Chief Operating Officer effective 1 April 2020. McKew …
alimera_sciences_logo

Steven T Gill returns to Alimera as VP, Thought Leader Engagement

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alimera Sciences, Novartis, pharma

Ophthalmology specialist Alimera Sciences has announced that Steven T Gill is to return to the company in the newly created …
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

COVID-19 coronavirus treatments dominate the news as the world looks for a vaccine. Johnson & Johnson announced that it has …

Axsome’s late-stage study of experimental depression drug misses main trial goal

March 31, 2020 Manufacturing and Production Depressive Disorder, MDD, depression, migraine

Axsome Therapeutics reported on Monday that its Phase 3 study of its experimental depression drug missed its main trial goal. …
000_jjjj

Johnson & Johnson selects lead COVID-19 vaccine candidate and targets September Phase I study

March 31, 2020 Manufacturing and Production . Johnson & Johnson, Johnson & Johnson, Vaccine, coronavirus, coronavirus vaccine

Johnson & Johnson announced that it has selected a candidate for a COVID-19 vaccine from potential constructs it has been …
The Gateway to Local Adoption Series

Latest content